Prevention of Diabetic Renal Disease with Special Reference to Microalbuminuria
In the past year six sets of recommendations on the prevention of diabetic nephropathy, with special reference to microalbuminuria, have been published [1–6]. The background to this activity was the large and increasing number of diabetic patients in whom end-stage renal failure (ESRD) develops and who therefore require dialysis or renal transplantation. Throughout the world about half a million patients are registered as being on renal replacement therapy, and diabetic nephropathy is the cause in nearly one-fifth of them . These data are extrapolated from countries which have registeries but in many areas, especially in the densely populated countries of the Far East, accurate information on numbers of patients with ESRD is not yet available. Moreover, the half-million figure probably underestimates the number of diabetic patients with ESRD because selection criteria for renal replacement therapies vary from country to country. Both insulin dependent (IDDM) and non-insulin-dependent (NIDDM) diabetic patients contribute to the increase in ESRD. Prevention of diabetic renal disease, or at least the postponement or slowing down of the disease process, has emerged as a key issue. Our strategy is to develop programmes for all patients with diabetes, focused on early detection of renal diseasefollowed by intervention.
KeywordsDiabetic Nephropathy Urinary Albumin Excretion IDDM Patient Diabetic Renal Disease High Blood Pressure Education Program
Unable to display preview. Download preview PDF.
- 1.Viberti GC, Mogensen CE, Passa P, Bilous R, Mangili R. »St Vincent declaration, 1994: Guidelines for the prevention of diabetic renal failure.« In The Kidney and Hypertension in Diabetes Mellitus, 2nd ed, Mogensen CE, ed. Boston, Dordrecht, London: Kluwer Academic Publishers, 1994; pp 515–527.CrossRefGoogle Scholar
- 2.Anon. Prevention of Diabetes Mellitus: report of a WHO study group. WHO Tech Rep Ser 844. Geneva: WHO, 1994: 55-59.Google Scholar
- 4.Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1994; 17: 1357–1361.Google Scholar
- 5.Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving H-H, Steffes MW, Striker GE. Screening and management of microalbuminuria in patients with diabetes mellitus — recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the council on diabetes mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25: 107–112.PubMedCrossRefGoogle Scholar
- 20.Hutchinson AS, O’Reilly DSTJ, MacCuish AC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 1988; 34: 2019–2021.Google Scholar
- 22.Mogensen CE, Poulsen PL, Heinsvig EM. »Abnormal albuminuria in the monitoring of early renal changes in diabetes.« In Concepts for the Ideal Diabetes Clinic. Diabetes Forum Series, Volume IV. Mogensen CE, Standi E, eds. Berlin, New York: Walter de Gruyter, 1993; pp 289–313.Google Scholar
- 24.Anon. Fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-183.Google Scholar
- 25.Anon. Guidelines for management of mild hypertension: memorandum from a WHO/ISH meeting. Clin Exp Hypertens 1993; 15: 1363-1395.Google Scholar
- 36.Mathiesen ER, Hommel E, Smith U, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria: 8 years follow-up (Abstract). Diabetologia 1995; 38: 1746.Google Scholar
- 39.Mogensen CE, Hansen KW, Nielsen S, Mau Pedersen M, Rehling M, Schmitz A. Monitoring diabetic nephropathy: Glomerular filtration rate and abnormal albuminuria in diabetic renal disease: Reproducibility, progression studies and efficacy of antihypertensive intervention. Am J Kidney Dis 1993; 22: 174–187.PubMedGoogle Scholar
- 48.Hasslacher C, Borgholte G, Ritz E, Wahl P. Impact of hypertension on prognosis of IDDM. Diabete Metab (Paris) 1989; 15: 338–342.Google Scholar